Prelude Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $5,640 | $6,500 | $0 | $0 |
Gross Profit | 5,222 | 6,075 | -433 | -435 |
EBITDA | -16,930 | -19,300 | -31,761 | -34,171 |
EBIT | -17,348 | -19,725 | -32,194 | -34,606 |
Net Income | -16,457 | -19,725 | -31,231 | -32,085 |
Net Change In Cash | 5,640 | 6,500 | 0 | 0 |
Free Cash Flow | 23,119 | -19,115 | -26,095 | -34,278 |
Cash | 35,256 | 47,532 | 25,752 | 40,269 |
Basic Shares | 62,953 | 76,132 | 75,993 | 75,986 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $12,140 | $7,000 | $0 | $0 |
Gross Profit | 10,429 | 7,000 | -1,169 | -3,042 |
EBITDA | -102,855 | -137,942 | -131,108 | -122,216 |
EBIT | -104,566 | -139,714 | -132,276 | -123,540 |
Net Income | -99,498 | -127,173 | -121,832 | -107,336 |
Net Change In Cash | 12,140 | 7,000 | 0 | 0 |
Free Cash Flow | -56,369 | -103,652 | -110,576 | -86,748 |
Cash | 35,256 | 12,474 | 25,291 | 30,605 |
Basic Shares | 76,956 | 75,805 | 60,357 | 47,371 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.20 |
2025-09-30 | -$0.26 |
2025-06-30 | -$0.41 |
2025-03-31 | -$0.42 |